Mariner
VERA icon

Mariner’s Vera Therapeutics VERA Stock Holding History

Mariner’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,635
Closed -$307K – 3915
2026
Q1 		$307K Sell
7,635
-154
-2% -$6.63K ﹤0.01% 2846
2025
Q4 		$394K Buy
+7,789
New +$277K ﹤0.01% 2627
2025
Q1 		– Sell
-5,966
Closed -$252K – 3597
2024
Q4 		$252K Buy
5,966
+171
+3% +$7.57K ﹤0.01% 2788
2024
Q3 		$256K Sell
5,795
-424
-7% -$16.1K ﹤0.01% 2715
2024
Q2 		$225K Sell
6,219
-664
-10% -$26.3K ﹤0.01% 2685
2024
Q1 		$297K Buy
+6,883
New +$245K ﹤0.01% 2437
2023
Q4 		– Sell
-11,038
Closed -$151K – 3178
2023
Q3 		$151K Buy
+11,038
New +$189K ﹤0.01% 2596

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Mariner's VERA Position: Q2 2026 in Review

Mariner sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 7,635 shares — an estimated $307K sold.

Mariner first reported a position in VERA in Q3 2023 and held it in 7 quarters. The position peaked at $394K in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Mariner reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Mariner sold 7,635 Vera Therapeutics shares in Q2 2026, an estimated $307K.
  • Mariner first reported a position in Vera Therapeutics in Q3 2023 and held it in 7 quarters.
  • Mariner's Vera Therapeutics position peaked at $394K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.